LeafNLP Demos
Back to explore

Report #2898800

Received Jun 3, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
CO
Recovered
Unknown
Vaccinated
May 7, 2026
Onset
May 7, 2026
Days to onset
0
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
HEPHEP B (RECOMBIVAX HB)MERCK & CO. INC.UNKZ010142—
MMRMEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.UNKZ006283—

Symptoms (2)

No adverse eventProduct storage issue

Symptom narrative

no additional AE; MMR-II and RECOMBIVAX HB were administered on the same date to a patient after a TE excursion; This Spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's medical history, past medications, and concomitant medications were not reported. On 07-May-2026, the patient was vaccinated with improperly stored dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live powder and solvent for solution for injection (M-M-R II) (Batch/Lot Number: Z006283, expiration date: 19-Mar-2027) reconstituted with sterile diluent (lot # not provided), and hepatitis B vaccine (Recombinant) (RECOMBIVAX HB), 5 mcg/0.5mL Suspension for injection 64457246:4093 (Batch/Lot Number: Z010142, expiration date: 09-Feb-2028) (improper storage of product in use). The vaccines underwent a temperature excursion of 65 Fahrenheit for 6 hours. There was no previous temperature excursion. No additional adverse event was reported. Lot # is being requested and will be submitted if received.

Other medications

MERCK STERILE DILUENT